Log in
Enquire now
‌

US Patent 9981987 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Patent 9981987 was granted and assigned to Karus Therapeutics on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Karus Therapeutics
Karus Therapeutics
0
Current Assignee
Karus Therapeutics
Karus Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99819870
Patent Inventor Names
Alexander Richard Liam Cecil0
Stephen Joseph Shuttleworth0
Franck Alexandre Silva0
Date of Patent
May 29, 2018
0
Patent Application Number
151176060
Date Filed
February 12, 2015
0
Patent Citations Received
‌
US Patent 11708378 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
0
‌
US Patent 11779586 Compounds comprising tricyclic heterocyclic compounds
Patent Primary Examiner
‌
Rebecca L Anderson
0
Patent abstract

A compound of formula I:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9981987 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.